Current asthma guidelines may not identify young children who have experienced significant morbidity

Pediatrics

Volumn 117, Issue 4, 2006, Pages 1038-1045

  Galant, Stanley P ^a,c   Morphew, Tricia ^b   Amaro, Silvia ^a   Liao, Otto ^a  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^b Southern California Chapter of the Asthma and Allergy Foundation of America   (United States)

^c NONE   (United States)

Author keywords

Asthma; Asthma control; Asthma exacerbation; Guidelines; Inner city

Indexed keywords

ABSENTEEISM; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; EDUCATION PROGRAM; FEMALE; HEALTH CARE UTILIZATION; HISPANIC; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD INTERMITTENT ASTHMA; MORBIDITY; PRESCHOOL CHILD; PRIORITY JOURNAL; VALIDATION PROCESS; CHILD; CLASSIFICATION; LUNG FUNCTION TEST; PRACTICE GUIDELINE; SCHOOL HEALTH SERVICE; VALIDATION STUDY;

ASTHMA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PRACTICE GUIDELINES; RESPIRATORY FUNCTION TESTS; SCHOOL HEALTH SERVICES; SEVERITY OF ILLNESS INDEX;

EID: 33646382384     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-1076     Document Type: Article

References (41)

1. Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, Redd SC. Surveillance for asthma: United States, 1980-1999. MMWR Surveill Summ. 2002;51(1):1-13
2. Taylor WR, Newacheck PW. Impact of childhood asthma on health. Pediatrics. 1992;90:657-662
3. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis 1. Assessing the economic impact. J Allergy Clin Immunol. 2001;107:3-8
4. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in first six years of life. N Engl J Med. 1995;332:133-138
5. Connett GJ, Warde C, Wooler E, Lenney, W. Use of budesonide in severe asthmatics age 1-3 years. Arch Dis Child. 1993;69:351-355
6. Skoner DP. Outcome measures in childhood asthma. Pediatrics. 2002;109:393-398
7. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. J Respir Med. 1994;88:373-381
8. Teper AM, Kofman CD, Szulman GA, Vidaurreta SM, Maffey AF. Fluticasone improves pulmonary function in children under two years old with risk factors for asthma. Am J Respir Crit Care Med. 2005;171:587-590
9. O'Byrne PM, Cuddy L, Taylor DW, Birch S, Morris S, Syrotuik J. Efficacy and cost benefit of inhaled corticosteroids in patients considered to have mild asthma in primary care practice. Can Respir J. 1996;3:169-175
10. Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. Impact of inhaled anti-inflammatory therapy on hospitalization and emergency room department visits for children with asthma. Pediatrics. 2001;107:706-711
11. Grant EN, Daugherty SR, Moy JM. Prevalence and burden of illness for asthma and related symptoms among kindergarteners in Chicago public schools. Ann Allergy Asthma Immunol. 1999;83:113-120
12. Ortega AN, Gergen PJ, Paltiel AD, Bauchner H, Belanger KD, Leaderer BP. Impact of site of care, race and Hispanic ethnicity on medication use for childhood asthma. Pediatrics. 2002; 109(1). Available at: Available at: www.pediatrics.org/cgi/content/full/109/1/e1
13. National Asthma Education and Prevention Program (NAEPP). Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health; 1991. Pub No. 91-3642
14. National Asthma Education Prevention Program (NAEPP). Expert Panel Report 2, Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health; 1997. Pub No. 97-4151
15. National Asthma Education and Prevention Program (NAEPP). Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma, Update on Selected Topics 2002. Bethesda, MD: National Institutes of Health; 2002. Pub No. 02-5075
16. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000;162:1403-1406
17. Finkelstein JA, Lozano P, Shulruff R, et al. Self-reported physician practices for children with asthma: are national guidelines being followed? Pediatrics. 2000;106:886-896
18. Berg AO, Moy JG. Clinical guidelines and primary care guidelines for the diagnosis and management of asthma. J Am Board Fam Pract. 1992;5:629-634
19. Pauwels RA, Pederson S, Busse WW, et al. Early intervention with budesonide in mild persistent asthma: the randomized double-blind trial. Lancet. 2003;361:1071-1076
20. Robertson CF, Rubinfeld AA, Bowes G. Pediatric asthma deaths in Victoria: the mild are at risk. Pediatric Pulmonol. 1992;13: 95-100
21. Fuhlbrigge AL, Adams RJ, Guilbert TW, et al. The burden of asthma in the United States. Level and distribution are dependent on interpretations of the National Education and Prevention Program Guidelines. Am J Respir Crit Care Med. 2002;166:1044-1049
22. Jones CA, Morphew T, Clement LT, et al. A school-based identification process for identifying inner city children with asthma. The Breathmobile program. Chest. 2004;125:924-934
23. Bloomberg GR, Trikus KM, Fischer EB Jr, Musick JR, Strunk RC. Hospital readmissions for childhood asthma. Am J Respir Crit Care Med. 2003;167:10678-1076
24. Johnston NW, Johnston SL, Duncan JM, et al. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol. 2005;115:132-138
25. Mitchell EA, Bland Jm, Thompson JMD. Risk factors for readmission to hospital for asthma in childhood. Thorax. 1994;49:33-36
26. To T, Dick P, Feldman W, Hernandez R. A cohort study in childhood asthma admissions and readmissions. Pedatrics. 1996;98:191-195
27. Crane J, Pearis N, Burgess C, Woodman K, Robson B, Beasley R. Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol. 1992;21:737-744
28. Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M, Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med. 2000;161:9-16
29. Osborne MO, Vollmer WM, Pediola KP, Wilkins J, Buist AS, O'Hollaren M. Lack of correlation of symptoms with specialists-assessed long term asthma severity. Chest. 1999;115:85-91
30. Warman KL, Silver EJ, Stein RER. Asthma symptoms, morbidity, and antiinflammatory use in inner-city children. Pediatrics. 2001;108:277-282
31. Ng TP. Validity of symptoms and clinical measures of asthma severity for a primary outpatient assessment of adult asthma. Br J Gen Pract. 2000;50:7-12
32. Diette GB, Krishman JA, Wolfenden LL, Skinner EA, Steinwachs DM, Wu AW. Relationship of physician estimate of underlying asthma severity to asthma outcomes. Ann Allergy Asthma Immunol. 2004;93:546-552
33. Bacharier LB, Strunk RC, Mauger D, White D, Lemanske RF Jr, Sorkness CA. Classifying asthma severity in children. Mismatch between symptoms, medication use and lung function. Am J Resp Crit Care Med. 2004;176:426-432
34. Galant SP, Crawford LJR, Norfew T, Jones CA, Bassin S. Predictive value of a cross-cultural asthma case-detection tool in an elementary school population. Pediatrics. 2004;114(3). Available at: www.pediatrics.org/ cgi/content/full/114/3/e307
35. American Thoracic Society Board of Directors. Standardization of spirometry: 1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis. 1987;136:1285-1298
36. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow volume curve with growth in aging. Am Rev Respir Dis. 1983;127:725-734
37. Martinez FP, Godfrey S. Wheezing Disorders in the Preschool Child: Pathophysiology and Management. Independence, KY: Martin Duntz; 2003
38. Harlone SD, Linet MS. Agreement between question data and medical records: the evidence for accuracy and recall. Am J Epidemiol. 1989;129:233-248
39. Strunk RC, Szefler SJ, Phillips BR. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allerg Clin Immunol. 2003;112:883-892
40. Wolthers OD, Pedersen S. Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids. Pediatrics. 1992;89:839-842
41. O'Byrne PM. Pharmacologic interventions to reduce the risk of asthma exacerbations. Proc Am Thorac Soc. 2004;1:105-108